Axiom Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Axiom Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-500	Closed	-$31K	–	92
2021 Q4	$31K	Hold	500	–	–	0.03%	129
2021 Q3	$37K	Hold	500	–	–	0.04%	127
2021 Q2	$46K	Sell	500 -200	-29%	-$17K	0.04%	142
2021 Q1	$62K	Buy	+700	New	+$69.4K	0.05%	152
2020 Q4	–	Sell	-1,500	Closed	-$96K	–	132
2020 Q3	$96K	Buy	1,500 +500	+50%	+$29.3K	0.11%	111
2020 Q2	$52K	Buy	+1,000	New	+$42.9K	0.07%	108

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Axiom Investment Management's ARKG Position: Q1 2022 in Review

Axiom Investment Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 500 shares — an estimated $31K sold.

Axiom Investment Management first reported a position in ARKG in Q2 2020 and held it in 6 quarters. The position peaked at $96K in Q3 2020. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Axiom Investment Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Axiom Investment Management sold 500 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $31K.
Axiom Investment Management first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 6 quarters.
Axiom Investment Management's ARK Genomic Revolution ETF position peaked at $96K in Q3 2020.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Axiom Investment Management's 13F filing for Q1 2022, filed 13 May 2022.